Key result
Dietary soy isoflavones reduce atherosclerosis by ~24% via estrogen receptor-alpha pathways.
Why the study?
The mechanisms by which dietary soy inhibits atherosclerosis and the role of estrogen receptor subtypes in mediating soy isoflavones' atheroprotective effects were unclear.
Does a diet rich in soy isoflavones reduce atherosclerosis in apolipoprotein E-deficient mice, and is it dependent on estrogen receptor subtypes?
Does a diet rich in soy isoflavones reduce atherosclerosis in apolipoprotein E-deficient mice, and is it dependent on estrogen receptor subtypes?
Answers are grounded in this paper and cite their sources.
Dietary soy isoflavones exert atheroprotective effects in a mouse model through mechanisms that specifically require the presence of estrogen receptor-α.
Objective—Although the mechanisms by which dietary soy inhibits atherosclerosis are unclear, one line of evidence implicates an important role for its phytoestrogenic isoflavones. We sought to determine whether soy isoflavones exert atheroprotective effects through estrogen receptor–dependent processes and, if so, which estrogen receptor subtype (ie, α or β) is involved.Methods and Results—We compared the effects of diets rich in soy protein that were either isoflavone depleted (0.04 mg/g protein isolate) or isoflavone-replete, or Soy(+IF) (1.72 mg/g protein isolate) in apolipoprotein E–deficient (ee) mice that had been crossed with estrogen receptor-α– and -β–deficient mice to produce double-knockout ααeeand ββeemice and (estrogen receptor) wild-type controls (AAeeand BBee). Both male and ovariectomized female mice were studied (n=10 to 17 per treatment group; total n=201). After 16 weeks, atherosclerosis was assessed by quantifying the aortic content of esterified cholesterol. Atherosclerosis was reduced 20% to 27% (P<0.05) by Soy(+IF) in ββee, BBee, and AAeemice but was unaffected in ααeemice. The inhibitory effect of Soy(+IF) was unrelated to sex, total plasma cholesterol, VLDL, LDL, and HDL cholesterol.Conclusions—The results indicate a necessary role for estrogen receptor-α–dependent processes in mediating the atheroprotective effects of dietary soy isoflavones.
No takes yet. Share an insight, caveat, or question.
Adams et al. (2002) studied Atherosclerosis (n=201). Dietary soy isoflavones (Soy(+IF)) vs. Isoflavone-depleted soy protein diet (0.04 mg/g protein isolate) was evaluated on Atherosclerosis (aortic content of esterified cholesterol) (reduced 20% to 27%, p=<0.05). Dietary soy isoflavones reduced atherosclerosis by 20% to 27% in wild-type and estrogen receptor-beta knockout mice, but not in estrogen receptor-alpha knockout mice.
Synapse has enriched 10 related papers. Consider them for comparative context: